Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma

Abroad (travel likely)RecruitingPHASE1

Conditions

Glioblastoma · High-grade Glioma · Malignant Glioma · Recurrent Glioblastoma · Recurrent High-grade Glioma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
Contact: Study coordinator (Zhen J Peng, Phd) · Zhen-Peng@beijing-biotech.com · +8613076790039

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma

Astrocytoma · Glioma · Recurrent Glioblastoma

Abroad (travel likely)RecruitingPHASE1

Bethesda, United States

PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications

Glioma · Medulloblastoma · Ependymoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Bethesda, United States

Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

Glioblastoma · Anaplastic Astrocytoma · Anaplastic Oligoastrocytoma

Abroad (travel likely)RecruitingPHASE2

New York, United States

BC008-1A Injection for Recurrent CNS WHO G4 Glioma

Glioma · Glioma Tumor Recurrence · Glioma, Recurrent High Grade

Abroad (travel likely)RecruitingPHASE1

Beijing, China